低剂量环胺与标准免疫抑制疗法相结合,改善了严重无形成性贫血的早期反应率
Hong Pan1,2,3, Zhen Gao1,2,3, Lele Zhang1,2,3
1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Frontiers in immunology
|February 16, 2026
概括
将低剂量环胺 (CTX) 添加到标准免疫抑制疗法 (IST) 中,改善了严重无形成性贫血 (SAA) 患者的早期反应率. 这种组合疗法显示出可控毒性,为SAA/VSAA提供了有前途的新治疗选择.
科学领域:
- 血液学 血液学 血液学
- 免疫抑制是一种免疫抑制.
- 无形成性贫血研究研究
背景情况:
- 标准免疫抑制疗法 (IST) 治疗严重/非常严重的无形成性贫血 (SAA/VSAA) 涉及血栓蛋白质受体激动剂,抗胸细胞球蛋白 (ATG) 和环素 (CsA).
- 目前的一线IST疗法在SAA/VSAA患者中表现出低于最佳的早期反应率.
- 环胺 (CTX) 已在复发性/耐药性无性贫血 (AA) 中表现出先前的疗效.
研究的目的:
- 评估低剂量环胺 (CTX) 与标准IST相结合的疗效,作为SAA/VSAA的第一线治疗.
- 为了提高新诊断的SAA/VSAA患者的早期反应率,使用这种新型组合疗法.
主要方法:
- 一个单臂前性II期临床试验与43名新诊断的SAA/VSAA患者进行.
- 患者接受了猪类抗胸细胞球蛋白 (ATG),环素 (CsA),异构巴格和低剂量环胺 (CTX).
- 主要终点是3个月的整体响应率 (ORR),治疗持续6个月.
主要成果:
- 所有43名患者都实现了主要终点,其3个月和6个月的ORR分别为65.1%和69.8%.
- 完全响应 (CR) 率在3个月后为9.3%,在6个月后为27.9%.
- 与CTX相关的毒性包括1~2级的胃肠道反应和3~4级的中性质衰竭;60.5%的患者在3个月内感染,但没有观察到死亡率.
结论:
- 低剂量环胺 (CTX) 结合标准IST显著改善SAA/VSAA患者的早期反应率.
- 这种组合疗法显示出可管理的毒性概况.
- 这些发现表明,SAA/VSAA.的新一线治疗策略是有前途的.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
561
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
561
Bone Marrow Sampling and Transplants
1.5K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.5K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
536
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
536
Immunodeficiency Diseases
2.5K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
2.5K
Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Stem Cell Therapy for Tissue Regeneration
4.7K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.7K


